{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:19:11Z","timestamp":1791051551133,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":563,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ccr.2011.11.023","type":"journal-article","created":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T18:59:53Z","timestamp":1326826793000},"page":"82-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":311,"title":["Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs"],"prefix":"10.1016","volume":"21","author":[{"given":"Astrid\u00a0A.M.","family":"Van\u00a0der\u00a0Veldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lubberink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idris","family":"Bahce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maudy","family":"Walraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel\u00a0P.","family":"de\u00a0Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri\u00a0N.J.M.","family":"Greuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.\u00a0Harry","family":"Hendrikse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert\u00a0D.","family":"Windhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter\u00a0E.","family":"Postmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk\u00a0M.","family":"Verheul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik\u00a0H.","family":"Sern\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan\u00a0A.","family":"Lammertsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert\u00a0F.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2011.11.023_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","article-title":"AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients","volume":"11","author":"Batchelor","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2011.11.023_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11307-005-0007-2","article-title":"Evaluation of basis function and linear least squares methods for generating parametric blood flow images using 15O-water and Positron Emission Tomography","volume":"7","author":"Boellaard","year":"2005","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.ccr.2011.11.023_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","article-title":"Mechanisms of angiogenesis and arteriogenesis","volume":"6","author":"Carmeliet","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrclinonc.2009.94","article-title":"Adverse effects of anticancer agents that target the VEGF pathway","volume":"6","author":"Chen","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"Suppl 16","key":"10.1016\/j.ccr.2011.11.023_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.seminoncol.2003.08.013","article-title":"A phase I\/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer","volume":"30","author":"Cobleigh","year":"2003","journal-title":"Semin. Oncol."},{"issue":"Suppl","key":"10.1016\/j.ccr.2011.11.023_bib6","first-page":"2204","article-title":"Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment","volume":"53","author":"Curti","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2011.11.023_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/HYPERTENSIONAHA.110.155762","article-title":"Receptor tyrosine kinase inhibition, hypertension, and proteinuria: is endothelin the smoking gun?","volume":"56","author":"Dhaun","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ccr.2011.11.023_bib8","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1200\/JCO.2007.15.4385","article-title":"Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer","volume":"26","author":"Dunnwald","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccr.2011.11.023_bib9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2011.11.023_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccr.2011.11.023_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc882","article-title":"Molecular imaging of cancer with positron emission tomography","volume":"2","author":"Gambhir","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2011.11.023_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2010.09.043","article-title":"DNA damage-mediated induction of a chemoresistant niche","volume":"143","author":"Gilbert","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2011.11.023_bib14","first-page":"3776","article-title":"Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications","volume":"59","author":"Griffon-Etienne","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2011.11.023_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1006\/nimg.1998.0379","article-title":"Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET","volume":"8","author":"Gunn","year":"1998","journal-title":"Neuroimage"},{"key":"10.1016\/j.ccr.2011.11.023_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2011.11.023_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s002590050279","article-title":"Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols","volume":"25","author":"Hermansen","year":"1998","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib18","first-page":"2109","article-title":"Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography","volume":"8","author":"Hoekstra","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccr.2011.11.023_bib19","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0969-8043(93)90181-9","article-title":"[15O]H2O, [15O]O2 and [15O]CO gas production, monitoring and quality control system","volume":"44","author":"Jackson","year":"1993","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2011.11.023_bib21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ccr.2011.11.023_bib23","doi-asserted-by":"crossref","first-page":"H560","DOI":"10.1152\/ajpheart.00133.2005","article-title":"VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature","volume":"290","author":"Kamba","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ccr.2011.11.023_bib24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nuclcard.2007.11.016","article-title":"Stroke volume measurements with first-pass dynamic positron emission tomography: comparison with cardiovascular magnetic resonance","volume":"15","author":"Knaapen","year":"2008","journal-title":"J.\u00a0Nucl. Cardiol."},{"key":"10.1016\/j.ccr.2011.11.023_bib25","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.06.1044","article-title":"Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)","volume":"24","author":"Kudoh","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccr.2011.11.023_bib26","first-page":"1784","article-title":"Parametric images of blood flow in oncology PET studies using [15O]water","volume":"41","author":"Lodge","year":"2000","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib27","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","volume":"357","author":"Miller","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/annonc\/mdm550","article-title":"Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation","volume":"19","author":"Mourad","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccr.2011.11.023_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1470-2045(07)70001-3","article-title":"Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study","volume":"8","author":"Ng","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccr.2011.11.023_bib30","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.ejca.2010.07.021","article-title":"Bevacizumab\/docetaxel association is more efficient than docetaxel alone in reducing breast and prostate cancer cell growth: a new paradigm for understanding the therapeutic effect of combined treatment","volume":"46","author":"Ortholan","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ccr.2011.11.023_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data","volume":"3","author":"Patlak","year":"1983","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ccr.2011.11.023_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1525-1411.2001.32007.x","article-title":"A phase II trial of humanized anti-vascular endothelial growth factor antibody for the treatment of androgen-independent prostate cancer","volume":"3","author":"Reese","year":"2001","journal-title":"The Prostate J."},{"key":"10.1016\/j.ccr.2011.11.023_bib33","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.HYP.38.2.238","article-title":"Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction","volume":"38","author":"Sern\u00e9","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ccr.2011.11.023_bib35","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2337\/diabetes.51.5.1515","article-title":"Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia","volume":"51","author":"Sern\u00e9","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ccr.2011.11.023_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccr.2008.08.001","article-title":"Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents","volume":"14","author":"Shaked","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2011.11.023_bib37","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1096\/fj.04-3178fje","article-title":"Alterations of beta-tubulin isotypes in breast cancer cells resistant to docetaxel","volume":"19","author":"Shalli","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.ccr.2011.11.023_bib38","first-page":"471","article-title":"Performance of Philips Gemini TF PET\/CT scanner with special consideration for its time-of-flight imaging capabilities","volume":"48","author":"Surti","year":"2007","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/11590180-000000000-00000","article-title":"Bevacizumab-induced hypertension: pathogenesis and management","volume":"25","author":"Syrigos","year":"2011","journal-title":"BioDrugs"},{"key":"10.1016\/j.ccr.2011.11.023_bib40","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2967\/jnumed.110.079137","article-title":"Quantitative parametric perfusion images using 15O-labeled water and a clinical PET\/CT scanner: test-retest variability in lung cancer","volume":"51","author":"van der Veldt","year":"2010","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib41","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s00259-010-1489-y","article-title":"Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients","volume":"37","author":"Van der Veldt","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ccr.2011.11.023_bib42","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1158\/1078-0432.CCR-10-2933","article-title":"Absolute quantification of [11C]docetaxel kinetics in lung cancer patients using positron emission tomography","volume":"15","author":"Van der Veldt","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccr.2011.11.023_bib43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/jlcr.861","article-title":"Radiosynthesis of [11C]docetaxel","volume":"47","author":"van Tilburg","year":"2004","journal-title":"J.\u00a0Labelled Comp. Rad."},{"key":"10.1016\/j.ccr.2011.11.023_bib44","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.apradiso.2008.02.076","article-title":"Improved and semi-automated GMP-compliant radiosynthesis of [11C]docetaxel","volume":"66","author":"van Tilburg","year":"2008","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2011.11.023_bib45","first-page":"2187","article-title":"Platelet: transporter of vascular endothelial growth factor","volume":"3","author":"Verheul","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccr.2011.11.023_bib46","first-page":"1219","article-title":"Parametric imaging of myocardial blood flow with 15O-water and PET using the basis function method","volume":"46","author":"Watabe","year":"2005","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2011.11.023_bib48","first-page":"1592","article-title":"Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method","volume":"52","author":"Wilson","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2011.11.023_bib49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","article-title":"A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer","volume":"349","author":"Yang","year":"2003","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610811004466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610811004466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:55:13Z","timestamp":1761522913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610811004466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1535610811004466"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2011.11.023","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13940983.15396098","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.13940983.15769065","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2011.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}